Silver Sponsor

Allucent, formed from the recent merger of CATO SMS and Pharm-Olam, is a global clinical services organization uniquely positioned to serve small and mid-sized biotech companies. With more than 30 years of experience in over 60 countries, we have supported over 200 rare and orphan disease clinical studies across a variety of novel therapy classes and precision medicine including; gene therapies, GMO’s, stem cell therapies, and mRNA and antisense therapies. With an integrated approach encompassing regulatory, clinical, and scientific expertise, we’re adept at overcoming the challenges of delivering novel treatments to patients.


Get Involved At World Orphan Drug Congress USA


To Sponsor Or Exhibit


Justin Franks
t/ +1 914 819 3506




To Speak


Claire Murphy
t/ +1 646 619 1784




Marketing & Press Opportunities


Taylor Post
t/ +1 646 619 1785